IgM and IgA antibodies can be detected early during the 1st week of symptom onset, whereas IgG can be detected at around 14 days after the initiation of symptoms (61, 70, 72); however, given the short time elapsed since the beginning of the COVID-19 pandemic, it is not known how long the protecting levels of these blocking antibodies will remain active. This evidence concerns the gene CD79A and COVID-19.